Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats

To examine the effect of diacerein on vascular dysfunction in type 2 diabetic rats and elucidate the mechanism of diacerein. In a rat model, type 2 diabetes was induced by high-fat diet and streptozotocin. Vascular function was assessed in vascular reactivity experiment. The effect of diacerein (10...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Biochemical and biophysical research communications Ročník 585; s. 68 - 74
Hlavní autori: He, An, Shen, Jian, Xue, Yuzhou, Xiang li, Li, Yuanjing, Huang, Longxiang, Lv, Dingyi, Luo, Minghao
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier Inc 31.12.2021
Predmet:
ISSN:0006-291X, 1090-2104, 1090-2104
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:To examine the effect of diacerein on vascular dysfunction in type 2 diabetic rats and elucidate the mechanism of diacerein. In a rat model, type 2 diabetes was induced by high-fat diet and streptozotocin. Vascular function was assessed in vascular reactivity experiment. The effect of diacerein (10 or 20 mg/kg/day) on blood glucose, inflammation and insulin signaling, and modulators in vascular tissue in diabetic rats were investigated by molecular and biochemical approaches. In this study, diacerein inhibited diabetes-induced vascular dysfunction. Diacerein treatment normalized blood glucose, insulin tolerance test, inflammatory cytokine levels and nitric oxide synthases expression in diabetic rats. Moreover, diacerein inhibited NF-κB and NLRP3 pathways and activated insulin signaling pathway related proteins IRS-1 and AKT in diabetic rats. Diacerein improved vascular function effectively in diabetic rats by suppressing inflammation and reducing insulin resistance. These results suggest that diacerein may represent a novel therapy for patients with diabetes. •In our study, we found diacerein inhibited diabetes-induced vascular dysfunction for the first time.•Diacerein treatment normalized blood glucose, insulin resistance, inflammatory cytokine levels and endothelial nitric oxide synthase and inducible nitric oxide synthase expression in diabetic rats.•Diacerein inhibited NF-κB and NLRP3 pathways and activated insulin signaling pathway related proteins IRS-1 and AKT in diabetic rats.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
1090-2104
DOI:10.1016/j.bbrc.2021.11.017